Cel-Sci
CVM
#9811
Rank
โ‚น4.36 B
Marketcap
โ‚น546.00
Share price
-5.66%
Change (1 day)
-66.98%
Change (1 year)

Cel-Sci (CVM) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : โ‚น1.21 Billion

According to Cel-Sci 's latest financial reports the company's total liabilities are โ‚น1.21 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cel-Sci - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30โ‚น1.18 B-17.78%
2023-09-30โ‚น1.44 B-3.64%
2022-09-30โ‚น1.49 B4.09%
2021-09-30โ‚น1.43 B-6.39%
2020-09-30โ‚น1.53 B-3.84%
2019-09-30โ‚น1.59 B-25.64%
2018-09-30โ‚น2.14 B25.07%
2017-09-30โ‚น1.71 B0.36%
2016-09-30โ‚น1.70 B-21.72%
2015-09-30โ‚น2.18 B301.88%
2014-09-30โ‚น0.54 B109.75%
2013-09-30โ‚น0.25 B-45.79%
2012-09-30โ‚น0.47 B1.94%
2011-09-30โ‚น0.46 B5.69%
2010-09-30โ‚น0.44 B-75.02%
2009-09-30โ‚น1.77 B890.79%
2008-09-30โ‚น0.17 B-25.47%
2007-09-30โ‚น0.24 B-50.39%
2006-09-30โ‚น0.48 B1016.49%
2005-09-30โ‚น43.4 M-32.12%
2004-09-30โ‚น63.94 M-17.39%
2003-09-30โ‚น77.4 M-40.95%
2002-09-30โ‚น0.13 B439.42%
2001-09-30โ‚น24.3 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Curis
CRIS
โ‚น3.85 B 218.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น75.92 B 6,167.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น7.327 T 604,814.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚น22.15 B 1,729.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น2.966 T 244,819.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
โ‚น10.332 T 852,852.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น79.94 B 6,499.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.23 B-80.45%๐Ÿ‡บ๐Ÿ‡ธ USA